<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">47733</article-id><article-id pub-id-type="doi">10.7554/eLife.47733</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Evolutionarily conserved long-chain Acyl-CoA synthetases regulate membrane composition and fluidity</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-118861"><name><surname>Ruiz</surname><given-names>Mario</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118862"><name><surname>Bodhicharla</surname><given-names>Rakesh</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118867"><name><surname>Ståhlman</surname><given-names>Marcus</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4202-0339</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118863"><name><surname>Svensk</surname><given-names>Emma</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118865"><name><surname>Busayavalasa</surname><given-names>Kiran</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118866"><name><surname>Palmgren</surname><given-names>Henrik</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-159157"><name><surname>Ruhanen</surname><given-names>Hanna</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118868"><name><surname>Boren</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-118330"><name><surname>Pilon</surname><given-names>Marc</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3919-2882</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Chemistry and Molecular Biology</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff2"><institution content-type="dept">Department of Molecular and Clinical Medicine</institution>, <institution>University of Gothenburg</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff3"><institution content-type="dept">Molecular and Integrative Biosciences Research Programme</institution>, <institution>University of Helsinki</institution>, <addr-line><named-content content-type="city">Helsinki</named-content></addr-line>, <country>Finland</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-8036"><name><surname>Walther</surname><given-names>Tobias C</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, University of California, San Francisco</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>marc.pilon@cmb.gu.se</email> (MP);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>26</day><month>11</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e47733</elocation-id><history><date date-type="received"><day>16</day><month>04</month><year>2019</year></date><date date-type="accepted"><day>23</day><month>11</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Ruiz et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Ruiz et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-47733-v1.pdf"/><abstract><p>The human AdipoR1 and AdipoR2 proteins, as well as their <italic>C. elegans </italic>homolog PAQR-2, protect against cell membrane rigidification by exogenous saturated fatty acids by regulating phospholipid composition. Here, we show that mutations in the <italic>C. elegans</italic> gene <italic>acs-13</italic> help to suppress the phenotypes of <italic>paqr-2</italic> mutant worms, including their characteristic membrane fluidity defects. <italic>acs-13 </italic>encodes a homolog of the human acyl-CoA synthetase ACSL1, and localizes to the mitochondrial membrane where it likely activates long chains fatty acids for import and degradation. Using siRNA combined with lipidomics and membrane fluidity assays (FRAP and Laurdan dye staining) we further show that the human ACSL1 potentiates lipotoxicity by the saturated fatty acid palmitate: silencing ACSL1 protects against the membrane rigidifying effects of palmitate and acts as a suppressor of AdipoR2 knockdown, thus echoing the <italic>C. elegans </italic>findings. We conclude that <italic>acs-13 </italic>mutations in <italic>C. elegans </italic>and ACSL1 knockdown in human cells prevent lipotoxicity by promoting increased levels of polyunsaturated fatty acid-containing phospholipids.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>C. elegans</italic></kwd><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsrådet</institution></institution-wrap></funding-source><award-id>Dnr: 2016-03676</award-id><principal-award-recipient><name><surname>Pilon</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002794</institution-id><institution>Cancerfonden</institution></institution-wrap></funding-source><award-id>Dnr 16 0693</award-id><principal-award-recipient><name><surname>Pilon</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002805</institution-id><institution>Carl Tryggers Stiftelse för Vetenskaplig Forskning</institution></institution-wrap></funding-source><award-id>CTS 16:365</award-id><principal-award-recipient><name><surname>Pilon</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100008550</institution-id><institution>Diabetesfonden</institution></institution-wrap></funding-source><award-id>DIA2016-109</award-id><principal-award-recipient><name><surname>Pilon</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Henrik Palmgren, affiliated with AstraZeneca. The author has no competing interests to declare. The other authors declare that no competing interests exist..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. The lipidomics data is provided as a supplementary table.</p></sec><supplementary-material><ext-link xlink:href="elife-47733-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>